Stephen Chan

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer

G. Ball, I. Ellis, R. Rees, 2014, British Journal of Cancer.

The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2

G. Ball, I. Ellis, R. Rees, 2017, Oncotarget.

The prognostic significance of computerised tomography findings in women with liver metastases from breast cancer.

G. Balls, J. James, S. Chan, 2011, Breast.